ISR IMMUNE SYS.REGUL.

ISR IMMUNE SYS.REGUL.

Share · SE0008212195 · A2AGDK (XSTO)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ISR IMMUNE SYS.REGUL.
No Price
Share Float & Liquidity
Free Float -
Shares Float -
Shares Outstanding 69,01 M
Company Profile for ISR IMMUNE SYS.REGUL. Share
ISR Immune System Regulation Holding AB (publ) researches and develops drugs for the treatment of viral infections in Sweden. The company's product pipeline includes Covid-19 vaccine, HBV, HIV, and oncology. The company is headquartered in Stockholm, Sweden.

Company Data

Name ISR IMMUNE SYS.REGUL.
Company ISR Immune System Regulation Holding AB (publ)
Website https://israb.se
Primary Exchange XSTO NASDAQ STOCKHOLM AB
WKN A2AGDK
ISIN SE0008212195
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Ola S. Winqvist
Market Capitalization 97 Mio
Country Sweden
Currency SEK
Employees 0,0 T
Address Retzius vAeg 11, 171 65 Stockholm
IPO Date 2017-03-24

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB ISR.ST
More Shares
Investors who hold ISR IMMUNE SYS.REGUL. also have the following shares in their portfolio:
BOOZT AB
BOOZT AB Share
ISUZU MOTORS LTD
ISUZU MOTORS LTD Depository Receipt